摘要
目的:探讨通过阻断花生四烯酸(arachidonic acid,AA)代谢途径抑制胰腺癌细胞增殖.方法:将胰腺癌细胞SW1990分为对照组,M K886干预组、塞莱昔布(C e l e c o x i b)干预组,MK886+Celecoxib干预组,用RT-PCR法检测细胞白三烯B4受体1(leukotriene B4receptor 1,BLT1)mRNA,血管内皮生长因子(vascular endothelial growth factor,VEGF)mRNA的表达量变化,用Western blot检测磷酸化-Erk(phosphorylated-extracellular regulated protein,p-Erk)表达量变化.结果:MK886作用下,BLT1 mRNA、VEGF mRNA等表达量均减少(P<0.01),p-Erk表达量明显减少(P<0.05),Celecoxib作用下,VEGF mRNA表达量明显减少(P<0.01),BLT1 mRNA表达与对照组无明显差异,p-Erk表达量与MK886组比较明显增加(P<0.01),MK886+80?mol/L Celecoxib作用下,BLT1 mRNA、VEGF mRNA表达量明显减少(P<0.01),p-Erk表达量与对照组无明显差异.结论:花生四烯酸的两条代谢途径均与胰腺癌的发生及增殖均有密切关系,而抑制5-脂氧合酶(5-lipoxygenase)途径较环氧化酶2(cyclooxygenase 2)途径相比,抑制肿瘤细胞增殖作用更强.
AIM: To investigate the effect of inhibition of arachidonic acid metabolism on proliferation of pancreatic cancer cells. METHODS: Cultured pancreatic cancer SW1990 cells were treated with different concentrations of MK886, celecoxib, or MK886 + celecoxib. After treatment, the expression of leukotriene B4 receptor 1 (BLT1) and vascular endothelial growth factor (VEGF) mRNAs was detected by semi-quantitative RT-PCR and the expression of phosphorylated extracellular regulated protein (p-Erk) was measured by Western blot. RESULTS: Treatment with MK886 significantly decreased the expression of BLT1 and VEGF mRNAs (P 〈 0.01 for both) and p-Erk (P 〈 0.05).Treatment with celecoxib did not alter the expres- sion of BLT1 mRNA and decreased the expres- sion of VEGF mRNA compared with untreated cells (P 〈 0.01), but increased the expression of p-Erk compared with the MK886 group (P 〈 0.01). Treatment with MK886 and celecoxib significant- ly decreased the expression of BLT1 and VEGF mRNAs (P 〈 0.01 for both), but did not alter the expression of p-Erk. CONCLUSION: Both two pathways of ara- chidonic acid metabolism are associated with pancreatic cancer cell proliferation, with the pathway involving 5-1ipoxygenase being more important.
出处
《世界华人消化杂志》
CAS
北大核心
2014年第8期1106-1111,共6页
World Chinese Journal of Digestology